Scpharmaceuticals company information, Employees & Contact Information

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care Yahoo Finance

MannKind To Acquire scPharmaceuticals citybiz

Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash Stock Titan

FDA Approves Furosemide Injection (Furoscix) for Edema in CKD HCPLive

scPharmaceuticals Earnings: Cardiorenal Healthcare Leader Sets Q2 2025 Financial Review Stock Titan

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases Yahoo Finance

$10B Market Opportunity: MannKind Acquires FUROSCIX Maker scPharmaceuticals to Dominate Cardiorenal Space Stock Titan

MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal Fierce Pharma

scPharmaceuticals Announces FDA Approval of Supplemental GlobeNewswire

$10B Market Opportunity: MannKind Acquires FUROSCIX Maker scPharmaceuticals in Strategic Cardiorenal Expansion Stock Titan

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering GlobeNewswire

scPharmaceuticals Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results, Projecting Significant Revenue Growth Quiver Quantitative

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors GlobeNewswire

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update Yahoo Finance

scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit Yahoo Finance

scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion Yahoo Finance

MannKind to acquire scPharmaceuticals The Pharma Letter

MannKind to acquire scPharmaceuticals and its drug delivery tech Drug Delivery Business

With 42% stake, scPharmaceuticals Inc. (NASDAQ:SCPH) seems to have captured institutional investors' interest Yahoo Finance

MannKind to acquire scPharmaceuticals for up to $360M FirstWord Pharma

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates Yahoo Finance

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ... Yahoo Finance

scPharmaceuticals’ Furoscix sNDA gets FDA nod for CKD oedema Pharmaceutical Technology

MannKind Expands Cardiometabolic and Lung Portfolio with $360 Million Acquisition of scPharmaceuticals Pharmaceutical Executive

SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders Business Wire

scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease Stock Titan

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 Seeking Alpha

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH Business Wire

Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders Business Wire

>$370M annualized run rate: MannKind completes scPharmaceuticals acquisition, adds FUROSCIX Stock Titan

MannKind to buy scPharmaceuticals to expand its cardiometabolic business Seeking Alpha

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting Diagnostic and Interventional Cardiology

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure Diagnostic and Interventional Cardiology

MannKind to Acquire ScPharmaceuticals in $360M Deal USA Herald

MannKind Snaps Up scPharmaceuticals In Cardiorenal Expansion Citeline News & Insights

MannKind to buy scPharmaceuticals for up to $360M; Arnatar launches with $52M Endpoints News

scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX® Yahoo Finance

scPharmaceuticals names Tucker as CEO | Personnel Moves – May 1, 2017 Drug Delivery Business